Dave Weiner

Stock Analyst at Piper Sandler

(1.70)

# 3,472

Out of 5,154 analysts

9

Total ratings

50%

Success rate

5.17%

Average return

Main Sectors:

Healthcare Consumer Discretionary

Top Industries:

Diagnostics & Research Apparel Retail

Stocks Rated by Dave Weiner

	Stock	Action	Price Target	Current	Upside	Ratings	Updated
	MYGN Myriad Genetics	Maintains: Overweight	$9 → $8.5	$5.15	+65.05%	4	Nov 11, 2025
	LULU lululemon athletica inc.	Upgrades: Buy	n/a	$170.13	-	5	Dec 14, 2017

Myriad Genetics

Nov 11, 2025

Maintains: Overweight

Price Target: $9 → $8.5

Current: $5.15

Upside: +65.05%

lululemon athletica inc.

Dec 14, 2017

Upgrades: Buy

Price Target: n/a

Current: $170.13

Upside: -